Palomino Laboratories begins OTCQB trading
Analysis based on 7 articles · First reported Jul 13, 2026 · Last updated Jul 13, 2026
The listing on OTCQB Venture Market provides Palomino with greater access to capital markets, potentially attracting investors interested in AI infrastructure. However, as an OTC stock, liquidity and visibility remain limited compared to major exchanges.
Abbott Laboratories, Inc., an innovator in optical interconnect technologies for AI and high-performance computing, announced that its common stock began trading on the OTCQB Venture Market Venture Market under the ticker symbol PALX on July 10, 2026. The company's shares are also DTC eligible, enabling electronic clearing and settlement through the Depository Trust Company. This milestone increases Palomino's visibility in the investment community and supports its strategy to pursue a future listing on a national securities exchange. CEO Jeffrey B. Shealy highlighted the growing demand for faster, lower-power interconnect technologies driven by AI.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard